The difference between night and day: Circadian clock may offer protection to aging eyes
March 9th 2022Investigators studying old flies have gained some new insight into retinal degeneration, seeking an understanding "of the molecular mechanisms that drive age-associated changes and the external and internal factors that influence them.”
Read More
Penn names Jeng chairman of ophthalmology, director of Scheie Eye Institute
March 8th 2022Bennie H. Jeng, MD, a corneal specialist, will assume his new role at Penn in July, succeeding Joan O’Brien, who will assume a new role as the inaugural director of the Penn Medicine Center for Ophthalmic Genetics in Complex Diseases.
Read More
New York ophthalmologist gets 96-month prison sentence for healthcare fraud, COVID-19 loan fraud
March 7th 2022Ameet Goyal, MD, 58, recently pled guilty in the Southern District of New York to all charges for orchestrating a seven-year healthcare fraud scheme by falsely billing for millions of dollars of upcoded procedures, and also for fraudulently obtaining two government-guaranteed loans intended to help small businesses during the COVID-19 pandemic.
Read More
Study: Minorities with glaucoma facing cost barriers to medication
March 4th 2022In advance of World Glaucoma Week March 6-12, a study of 3826 patients with glaucoma has found significantly higher odds of self-reported difficulty affording medication observed among non-Hispanic African American and Hispanic individuals compared with non-Hispanic White individuals.
Read More
TearSolutions planning Phase II/III trials for therapy to treat dry eye disease
February 25th 2022TearSolutions Inc. is preparing to conduct two trials, one in a primary Sjögren’s Syndrome patient population and the second in a potentially less severe general dry eye population for the treatment of DED.
Read More
Prevent Blindness plans Eyes on Capitol Hill program on March 1-2
February 25th 2022The organization uses its Eyes on Capitol Hill program to educate lawmakers and their staff on a variety of vision health issues, including vision health inequities, the need for improved vision surveillance, the impact of community eye health programs, and disparities in access to affordable eyecare services.
Read More
Kodiak Sciences unveils results of Phase 2b/3 study for nAMD candidate
February 24th 2022KSI-301, a therapy for patients with nAMD, did not meet the primary endpoint of showing non-inferior visual acuity gains compared to aflibercept given every eight weeks, however it was safe and well tolerated with no new or unexpected safety signals.
Read More
The changing landscape of gene therapy and standardized endpoints
February 23rd 2022In this episode of EyePod, Ora Clinical’s Keith Lane offers a brief overview of the current state of ophthalmology and its standardized endpoints. He also discusses some of the challenges that gene therapy has faced, particularly in relation to ophthalmology. He also offers his outlook for the future of gene therapy.
Read More
EyeBiotech Ltd. raises $65 million to develop new eye disease therapies
February 22nd 2022The company will use proceeds from the Series A to assemble and develop a diversified pipeline of product candidates that combines scientifically compelling targets with innovative translational approaches.
Read More